Pure Global
NCT06223217

Development and Validation of the Modified Version of VascuQol Scale in Patients With Lower Extremity Peripheral Arterial Disease.

RenJi Hospital·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Peripheral Arterial Disease
Drug/Device/Intervention
Surveys and Questionnaires
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
RenJi Hospital
Location
Shanghai, China
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2023
End date
Dec 31, 2026
Enrollment
480 participants
Primary outcome

the Modified version of VascuQol Scale,the Chinese version of VascuQol Scale

Summary

The purpose of this study is to assess the utility of the Modified version of VascuQol Scale
 as an effective biopsychosocial assessment tool for patients suffering from lower extremity
 peripheral arterial disease.

ICD-10 classifications
Peripheral vascular disease, unspecifiedOther peripheral vascular diseasesOther specified peripheral vascular diseasesPeripheral angiopathy in diseases classified elsewhereOther congenital malformations of peripheral vascular system
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06223217
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06223217 through Pure Global AI's free database. This phase not specified trial is sponsored by RenJi Hospital and is currently Recruiting. The study focuses on Peripheral Arterial Disease. Target enrollment is 480 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.